20,903 new cases; ICMR bid to speed up Co­vaxin tri­als

The Asian Age - - Front Page - AGE COR­RE­SPON­DENT with agency in­puts

The In­dian Coun­cil of Med­i­cal Re­search has asked med­i­cal in­sti­tu­tions and hos­pi­tals to fast-track clin­i­cal trial ap­provals for in­dige­nous vaccine can­di­date Co­vaxin so that it can be launched by Au­gust 15.

Co­vaxin, de­vel­oped by Hy­der­abad-based Bharat Biotech in col­lab­o­ra­tion with ICMR and Pune’s Na­tional In­sti­tute of Virol­ogy, re­cently got the nod for hu­man clin­i­cal tri­als from the drugs con­troller. Twelve clin­i­cal trial sites have been iden­ti­fied, and ICMR has asked med­i­cal in­sti­tu­tions to en­sure sub­ject en­rol­ment is started by July 7. ICMR di­rec­tor­gen­eral Bal­ram Bhar­gava told the prin­ci­pal in­ves­ti­ga­tors of the 12 sites that it was among the “top pri­or­ity projects be­ing mon­i­tored at the high­est level of the gov­ern­ment”.

In­dia on Fri­day saw 20,903 new in­fec­tions, tak­ing the to­tal count to 6,25,544, while the death toll rose to 18,213 with 379 new fa­tal­i­ties, health min­istry data said. How­ever, the re­cov­ery rate is now 60.73 per cent, af­ter a sharp rise in re­cov­er­ies, with 20,033 Covid-19 pa­tients be­ing cured in one day, tak­ing the to­tal to 3,79,891. At present, there are 2,27,439 ac­tive cases un­der med­i­cal su­per­vi­sion.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.